While this study doesnt specifically look at eating disorders, it does suggest that people with eating disorders may be more likely to seek out GLP-1 medications
Kornblau SM, Thall PF, Estrov Z, Walterscheid M, Patel S, Theriault A, Keating MJ, Kantarjian H, Estey E, Andreeff M
The 52-week safety extension trial (Falutz et al., PMID 20101189) extended these observations and reported no new safety signals
Called GLP-1 receptor agonists (GLP-1RAs), the drugs were first developed to treat type 2 diabetes, but really took off when their potential as weight loss aids was recognized
Tuy nhin, c mt s trng hp ngi dng b nng trong ngi, ni mn hoc to bn sau khi s dng collagen, v y ch yu l do nhng nguyn nhn sau: Qu lm dng collagen: ung qu nhiu collagen ngoi kh nng hp th ca c th c th gy ra cc phn ng nh ni mn, to bn v cm gic nng trong ngi